BAILEY SAVAGE: Open Payments
NPI 1427759216 · HARRISON, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167 in 9 payments from 8 companies in 2025. Trend: 2023 $81 · 2024 $14 · 2025 $167
Food & beverage: $167
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Averitas Pharma Inc. | 1 | $28 |
| PFIZER INC. | 1 | $22 |
| Exeltis, USA Inc. | 1 | $20 |
| ConvaTec Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Boston Scientific Corporation | 1 | $14 |
Products named: QUTENZA, TRUMENBA, SLYND, AQUACEL AG+ EXTRA, AIRSUPRA, CAPLYTA, BREZTRI, Ozempic.
Industry payments across AR — which companies pay providers there.
